A comprehensive topical product system meticulously formulated for the targeted treatment of viral skin warts.

Categories: , ,
  1. General Details

    Despite the established viral origin of skin warts, the effectiveness of topical antiviral treatments has been restricted. In response to this challenge, WartOlyze® was created.

    • Unmatched Efficacy
      WartOlyze® is a solution for treating viral warts on the skin with clinically verifiation of 100% efficacy. This high success rate is consistent across all types of viral warts, making WartOlyze® a universally applicable treatment. Whether dealing with common warts, plantar warts, or flat warts, WartOlyze® delivers unparalleled results.
    • Versatile Applications
      Its pain-free application process ensures little to no post-procedure discomfort, making it a patient-friendly option. Patients can expect a smooth experience, free of side effects or clinical complications, which further enhances the appeal of WartOlyze®.
    • Long-Lasting Results
      One of the standout features of WartOlyze® is its minimal recurrence rates. Patients benefit from long-lasting results, reducing the need for repeat treatments.
    • Economic and Practical Benefits
      WartOlyze® is not only effective but also economical and commercially feasible. The swift procedures ensure rapid patient turnover, allowing clinics to treat more patients in less time.
    • Service Mobility
      Another significant advantage of WartOlyze® is its service mobility. This feature facilitates the establishment of a network of offices offering this technique. Clinics can easily incorporate WartOlyze® into their range of services, expanding their offerings and attracting more patients.

    If you are interested in WartOlyze®, please visit this link.

  2. Patent Portfolio
    • U.S. Patent Pub. No. 20230052709 – Topical antiviral liquid for treatment of warts
    • U.S. Patent App. No. 18/112,852 –  Topical composition for destroying, in vivo, an external hyperplastic tissue, such as, but not limited to, a viral skin lesion, such as, but not limited to, a viral wart
    • U.S. Patent App. No. 63/227,147 – Method of using a topical antiviral liquid for affecting etiological factors of viral warts
    • U.S. Patent App. No. 63/227,144 – Topical antiviral liquid for affecting etiological factors of viral warts
    • U.S. Patent App. No. 63/227,151 – Method for making the topical antiviral liquid for affecting etiological factors of viral warts
    • WARTOLYZE® Design Mark – Reg. No. 5,601,585
    • WARTOLYZE® Word Mark – Reg. No. 5,601,583
  3. Data Room Access & Additional Details

    Other Publicly Data Room Materials Available at VIP-3307 Public Data Room for Essential Remedium IP:

    • Other Introductory Materials
    • Patents, Trademarks, and Applications
    • Patent, Trademark, and Application File Histories
    • Product Pitch Decks
    • Videos
    • Non-Disclosure Agreement Draft to access more files listed below

    Additional Materials (available upon signing a mutual non-disclosure agreement):

    • Due Diligence Review
    • Assignments and Ownership
    • Valuations
    • Presentations
    • Clinical Reports
    • Earlier Business Plan
    • Regulatory Pathway
    • Additional Documents
  4. More Information

    Pricing guidance for this transaction may be available. All parties interested in the IP above are authorized to contact Spencer Rogers at Vibrant IP, LLC at spencer@vibrantip.com and 415-997-9772.